Trial intelligence / Profile preview

Safety and Efficacy of UHE-103 in Moccasin-Type Tinea Pedis

NCT03897257Phase 2Completed

Start
Mar 2019
Primary completion
Oct 2019
Countries
2
01

Overview

A Phase 2 trial of UHE-103 in tinea pedis. Started Mar 2019; status: completed.

02

Drugs

UHE-103
03

Conditions

tinea pedis

Beyond the preview

Go deeper on NCT03897257.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03897257.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call